A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: A RTOG randomized study (#79-04)

This publication has 22 references indexed in Scilit:

• Failure of misonidazole-sensitized radiotherapy to impact upon outcome among stage III–IV squamous cancers of the head and neck
  International Journal of Radiation Oncology*Biology*Physics, 1987
• Phase I trial of the hypoxic cell radiosensitizer SR-2508: The results of the five to six week drug schedule
  International Journal of Radiation Oncology*Biology*Physics, 1986
• Oxygen tension in human tumors: in vivo mapping using CT-guided probes.
  Radiology, 1985
• The value of adjuvant misonidazole in the definitive irradiation of advanced head and neck squamous cancer: An rtog pilot study (#78-02)
  International Journal of Radiation Oncology*Biology*Physics, 1981
• SR-2508: A 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use
  International Journal of Radiation Oncology*Biology*Physics, 1981
• Structure-activity Relationships in the Development of Hypoxic Cell Radiosensitizers
  International Journal of Radiation Biology, 1979
• RADIOTHERAPY AND HYPERBARIC OXYGEN IN HEAD AND NECK CANCER
  The Lancet, 1977
• RADIOTHERAPY AND HYPERBARIC OXYGEN IN HEAD AND NECK CANCER
  The Lancet, 1977
• Causes of Failure in Irradiation of Squamous-Cell Carcinoma of the Supraglottic Larynx
  Radiology, 1974
• The Concentration of Oxygen Dissolved in Tissues at the Time of Irradiation as a Factor in Radiotherapy
  The British Journal of Radiology, 1953